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The distribution of virulent factors (VFs) in 287 Shiga toxin-producing Escherichia coli (STEC) strains that
were classified according to Karmali et al. into five seropathotypes (M. A. Karmali, M. Mascarenhas, S. Shen,
K. Ziebell, S. Johnson, R. Reid-Smith, J. Isaac-Renton, C. Clark, K. Rahn, and J. B. Kaper, J. Clin. Microbiol.
41:4930–4940, 2003) was investigated. The associations of VFs with phylogenetic background were assessed
among the strains in comparison with the different seropathotypes. The phylogenetic analysis showed that
STEC strains segregated mainly in phylogenetic group B1 (70%) and revealed the substantial prevalence (19%)
of STEC belonging to phylogenetic group A (designated STEC-A). The presence of virulent clonal groups in
seropathotypes that are associated with disease and their absence from seropathotypes that are not associated
with disease support the concept of seropathotype classification. Although certain VFs (eae, stx2-EDL933, stx2-vha,
and stx2-vhb) were concentrated in seropathotypes associated with disease, others (astA, HPI, stx1c, and
stx2-NV206) were concentrated in seropathotypes that are not associated with disease. Taken together with the
observation that the STEC-A group was exclusively composed of strains lacking eae recovered from seropatho-
types that are not associated with disease, the “atypical” virulence pattern suggests that STEC-A strains
comprise a distinct category of STEC strains. A practical benefit of our phylogenetic analysis of STEC strains
is that phylogenetic group A status appears to be highly predictive of “nonvirulent” seropathotypes.
Shiga toxin-producing Escherichia coli (STEC) causes a
spectrum of human illness, including hemorrhagic colitis (HC)
and hemolytic-uremic syndrome (HUS) (21, 24, 29, 30). STEC
isolates that cause human infections belong to a large number
of O:H serotypes. E. coli O157:H7 is the most prevalent sero-
type associated with large outbreaks and sporadic cases of HC
and HUS in many countries (24, 29, 30). The O157:H7 strains
harbor a large pathogenicity island (PAI) termed the locus for
enterocyte effacement (LEE) encoding the different determi-
nants necessary for the development of the characteristic
attaching-and-effacing lesion on enterocytes (12, 20, 29).
LEE-positive serotypes are commonly referred to as entero-
hemorrhagic E. coli (EHEC) (19, 22). The LEE seems to
confer enhanced virulence since LEE-positive STEC are more
commonly associated with outbreaks and HUS than LEE-neg-
ative serotypes (5, 19). However, LEE-negative STEC strains
are also associated with severe human disease (17, 29), and
some serotypes of LEE-positive STEC isolated from cattle
have never been associated with human disease (50). These
observations suggest that other unknown factors, possibly PAIs
or genomic islands, may enhance the virulence potential of
STEC strains (19, 24, 31).
Shiga toxins (Stx1 and Stx2) are the most critical virulence
factors responsible for the principal manifestations of HUS
and HC (11, 26, 30, 41). STEC isolates producing Stx2 are
more commonly associated with severe disease (e.g., HUS)
compared to isolates producing Stx1 alone or Stx1 and Stx2 (5,
27, 41, 42). Although only three stx1 alleles were described, stx2
comprises at least 11 distinct subtypes (8, 30). Recently, we
described in bovine STEC strains a new stx2 subtype (stx2-
NV206) showing a high cytotoxicity for Vero cells (2). In addi-
tion, several other virulence factors, including adhesins and
plasmid-encoded virulence factors, contribute to the pathoge-
nicity of STEC strains (12, 19, 24). Potential virulence genes
such as the enteroaggregative E. coli heat-stable enterotoxin
(EAST1) gene (astA) associated with diarrheogenic E. coli
strains (3, 45, 51, 52) and PAIs such as the high pathogenicity
island (HPI) of Yersinia spp. were also detected in STEC
strains (2, 20).
A large variety of STEC serotypes have been implicated in
disease. However, certain STEC serotypes recovered from an-
imals and food have never been associated with severe human
disease. For a better understanding of the apparent differences
in virulence between groups of STEC serotypes, STEC strains
were classified into five seropathotypes (A to E) by Karmali et
al. (22), according to incidence and association with HUS and
outbreaks. Recent studies have demonstrated that the deter-
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mination of the seropathotype distribution of virulent factors
(VFs) allows identification of DNA targets for selective detec-
tion of strains that present a risk to public health (22, 43). Such
an approach has highlighted the association between the
genomic island EDL933 OI-122 and seropathotypes linked to
epidemic and/or severe disease (22).
To study their evolutionary relationship, different authors (7,
13, 37, 49) have studied the clonal relationship of STEC
strains. Based on multilocus enzyme electrophoresis analysis
and multilocus sequence typing, Whittam and coworkers have
studied the clonal relationships of STEC strains (STEC Ref-
erence Center [http://www.shigatox.net/stec/index.html]). Four
clonal groups have been identified: EHEC 1, EHEC 2, STEC
1, and STEC 2 (dendrograms showing these clonal groups may
be viewed at the STEC Reference Center Web site).
A strategy for investigating the evolutionary origins of
pathogenic E. coli is to determine the phylogenetic distribution
of the virulence determinants (14, 33, 37). Phylogenetic anal-
yses have shown that most E. coli strains belonged to four main
phylogenetic groups, A, B1, B2, and D (25, 37). Whereas most
commensal and diarrheogenic strains belong to groups A and
B1, extraintestinal E. coli strains belong mainly to group B2
and group D (14). Recent phylogenetic studies indicated that
STEC and EHEC strains fell into phylogenetic groups A, B1,
and D (4, 13, 14). However, there was a paucity of information
regarding the phylogenetic distribution of the virulence factors
of STEC strains.
In the present study, the distribution of selected VFs (stx1
and stx2 subtypes, eae, astA, and HPI) in a collection of 287
well-defined STEC isolates was determined and analyzed. The
first aim of the present study was to analyze the distribution of
VFs among isolates classified by seropathotypes. The second
aim was to examine the phylogenetic structure of the different
seropathotypes. Finally, we sought to analyze the association
between VFs and the genetic background of the strains based
on classification by phylogenetic and clonal groups.
MATERIALS AND METHODS
Bacterial strains. A total of 287 STEC isolates classified into four different sets
were used in the present study. The first set includes 172 bovine isolates which
are part of a well-characterized bacterial collection obtained during a 1-year
prospective study in the same geographic area in France (6, 36). The bovine
strains belonged to 74 serotypes. The second set comprised 50 STEC strains
originating from food samples collected in France (36). The third set is com-
posed of 11 environmental isolates collected in France from dairy cattle herd
manure, a wastewater treatment plant, and pig farm manure (46). The fourth set,
including 54 STEC strains of diverse geographic origins isolated from human
disease, was provided by the STEC Center, National Food Safety and Toxicology
Center, Michigan State University. Of the 287 STEC isolates, 274 belong to
non-O157 serotypes. They were found to be positive for the presence of stx1
variants (n 141), stx2 variants (n 243), or both (n 88) by PCR and Southern
hybridization (1, 2, 36, 46). Each strain was isolated from different patients,
animals, or foods and from environmental samples. Reference strains for geno-
typic detection were as previously reported (2, 34, 46).
Seropathotype classification. Based on their clinical and epidemiological fea-
tures, STEC strains are classified into the five seropathotypes described by
Karmali et al. (22). Seropathotypes A and B (29 strains) included strains with
serotypes known to be associated with HUS and outbreaks. Seropathotype C
included 96 isolates associated with sporadic HUS but not with outbreaks. Se-
ropathotype D included 70 isolates that were assigned according to the criteria
of low incidence in humans and no association with HUS. The 92 isolates
included in seropathotype E belong to serotypes that have not been found in
humans. Assignment of O:H serotypes to seropathotype groups was based on
published reports (17, 29, 50) and on three internet databases (available at
http://www.microbionet.com.au/vtec2u.htm, http://www.who.int/emcdocuments
/zoonoses/docs/whocsraph988.html, and http://www.lugo.usc.es/ecoli).
Nomenclature of Shiga toxin types. In the literature, different designations
have been used for the same genes, causing confusion. The stx1 abbreviation was
used interchangeably to designate all stx1-related genes or to designate the
original stx1 subtype found in the strain EDL933. Similarly, the term stx2 was used
to designate all stx2-related genes or only the stx2 subtype found in the EDL933
strain. In the present study, to avoid confusion, the term stx1 variants was
attributed to all stx1-related genes and stx2 variants refers to all stx2-related genes.
The terms stx1 and stx2 were reserved for the original subtypes found in the E. coli
EDL933 reference strain. Toxins of Shiga toxin type 2d include the genetically
closely related toxins (stx2d-Ount, stx2d-OX3a, and stx2d-O111). Shiga toxin type 2c is
reserved for the mucus-activatable toxins (stx2-vha and stx2-vhb) described by
Melton-Celsa et al. (28), and toxins of type 2e include the porcine edema
disease-associated toxins.
Subtyping of stx1 genes. In the present study, we developed a restriction
fragment length polymorphism (RFLP)-PCR system to discriminate the three
stx1 variants (stx1, stx1c, and stx1d). The three stx1 gene variants were first ampli-
fied by using the VT1-A (ACACTGGATGATCTCAGTGG) and VT1-B (CTG
AATCCCCCTCCATTATG) oligonucleotide primers at an annealing tempera-
ture of 55°C to obtain a 603-bp amplified PCR product. The amplicons were then
digested with the restriction endonucleases BglI, HaeI, and RsaI as recom-
mended by the manufacturer (Roche Applied Science). The amplified product
from STEC possessing stx1, stx1c, and stx1d generated fragments of 215 and 387
bp with BglI, 220 and 382 bp with RsaI, and 415 and 187 bp with HaeI, respec-
tively. The PCR products were separately digested with each restriction endo-
nuclease and incubated at 37°C for 4 h. Agarose gel (1.4%) electrophoresis was
used to separate the restricted fragments. The restriction enzymes were selected
by using the NEBcutter V2.0 program (http://tools.neb.com/NEBcutter2/index
.php). To validate the RFLP-PCR procedure, the results obtained were con-
firmed by PCR amplification as previously described using the VT1AvarF/
VT1AvarR and Lin-up/1OX3 primer pairs specific to the stx1d and stx1c variants,
respectively (9, 23).
Subtyping of stx2 genes. An RFLP-PCR system using the VT2c-VT2d primer
pair was used to distinguish stx2, stx2-vha, stx2-vhb, and stx2-NV206 subtypes (2, 35,
44). The VT2 cm-VT2f primer pair was used to detect stx2d (34). Using the
VTea-VTeb primer pair, the detection of the stx2e variant was performed as
described previously (18, 48).
Detection of the genes encoding intimin and enteroaggregative heat-stable
enterotoxin 1 and marker genes for the HPI of Yersinia spp. The intimin gene
(eae) included in the LEE pathogenicity island was detected by PCR amplifica-
tion as previously described (2, 36, 46). The astA gene encoding the EAST1
enteroaggregative E. coli heat-stable enterotoxin 1 was detected by Southern
hybridization with a DNA probe amplified using the east11a/east11b primer pair
(39, 51). The probe was labeled with alkali-labile DIG-dUTP (PCR DIG Probe
Synthesis Kit; Roche Diagnostics). The hybridization was performed at 42°C.
Chemiluminescence detection with CDP-Star (NEN) was done by exposure of
membranes to Hyper film ECL (Amersham Pharmacia Biotech). PCR detection
of the marker genes irp1, irp2, and fyuA specific to the HPI of Yersinia was
performed as described previously (40).
Phylogenetic group determination. The main phylogenetic groups (A, B1, B2,
and D) of the E. coli strains were determined by triplex PCR amplification as
described by Clermont et al. (10).
Statistical analysis. Statistical analyses were performed with SAS for Unix
Windows (version 8.01; SAS Institute, Cary, N.C.). Comparison of the preva-
lence for a particular characteristic in different populations was evaluated with
the chi-square test and odds ratios (ORs) with 95% confidence intervals (95%CI)
were determined. The threshold for statistical significance was P values of0.01.
RESULTS
Strain characterization. Serotypes, sources of isolation, and
virulence genotypes of the studied strains, sorted by seropatho-
type, are shown in Table 1. The 287 STEC strains included in
the five reported seropathotypes belonged to 107 different O:H
serotypes. All O157:H7 and O157:NM strains (13 isolates)
were included in seropathotype A. The seropathotype B com-
prised 16 strains belonging to serotypes O26:H11, O26:NM,
O103:H2, O111:NM, and O111:H2. The 96 strains in sero-
pathotype C belonged to 24 serotypes. The best-known sero-
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types that conform to the features of seropathotype C are
O91:H21, O113:H21, and O174:H21, but serotypes O8:H19,
O22:H8, O91:H10, O105:H18, and O174:H2, which were as-
sociated with HUS, were also included in seropathotype C.
The 70 strains in seropathotype D belonged to 32 serotypes.
The most commonly isolated serotypes included in seropatho-
type D are O22:H16, O113:H4, and O171:H2. The 92 strains in
seropathotype E belonged to 47 serotypes. The most com-
monly isolated serotypes included in seropathotype E are O6:
H10, O46:H38, O172:H21, and OX178:H19.
Distribution of studied virulent determinants among the
different seropathotypes. The studied virulent determinants
differed with respect to their distribution among the different
seropathotypes (Table 2). Compared to seropathotypes that
are not associated with disease (D and E, combined), sero-
pathotypes that are associated with disease (A, B, and C, com-
bined) exhibited a significant higher prevalence of various VFs
analyzed (specifically, eae, stx2, stx2-vha and stx2-vhb). Inversely,
astA, stx1c, and stx2-NV206 were significantly more prevalent
among seropathotypes D and E.
Of the 287 STEC strains, only 44 (15%) had the intimin gene
(eae) considered as a stable marker of the LEE. The preva-
lence of eae was significantly higher (P 0.0001) in seropatho-
types A, B, and C (linked to severe disease) than in seropatho-
types D and E (no link with disease) with an OR of 11.6,
revealing eae as a strong predictor of seropathotypes associ-
ated with severe disease.
The astA gene encoding the EAST1 enteroaggregative E.
coli heat-stable enterotoxin-1 was detected in 35 isolates
(12%). A substantial part (40%) of the astA gene was recov-
ered from strains which possessed only the stx1 subtype. The
prevalence of astA was significantly higher in seropathotypes D
and E (not linked to severe disease) than in seropathotypes A,
B, and C (linked with disease). The HPI also exhibited a
significant nonrandom distribution among the seropathotypes.
However, the difference in the prevalence of HPI between
seropathotypes associated or not with disease was not signifi-
cant.
The differences in the prevalence of stx1 variants or stx2
variants (alone or combined) between seropathotypes associ-
ated or not with disease were not significant. Subtyping re-
vealed the wide distribution of the stx1 among the five sero-
pathotypes. Consistent with previous studies indicating that
isolates that possess stx1c were recovered either from asymp-
tomatic patients or from healthy sheep (23), stx1c was more
frequent in seropathotypes D and E, which are not associated
with disease. The stx1d subtype that was commonly recovered
from sheep was not encountered in the present study.
Analysis of the stx2 genotype showed a significant nonran-
dom distribution of the different subtypes among the five se-
ropathotypes. The differences in the prevalence of stx2, stx2-vha,
and stx2-vhb between seropathotypes associated with disease
(A, B, and C, combined) and seropathotypes not associated
with disease (D and E, combined) was significant, favoring
seropathotypes that have been associated with disease. Anal-
ysis of the distribution of stx2-vhb in relation to the serotypes
indicates that stx2-vhb was restricted to eae-negative strains.
Interestingly, among these strains, the prevalence of stx2-vhb
was more than twice higher (56% versus 22%) among isolates
in seropathotype C than among isolates in seropathotypes D
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plus E (combined). This finding reveals stx2-vhb as a significant
predictor of the “virulent” status among the eae-negative
strains (P 0.0002; OR 4.2 [95%CI 2.3 to 7.3]). Similarly,
a significant higher prevalence of stx2-vha was found in sero-
pathotype C. Strains of several serotypes predominantly found
in seropathotype C (particularly O91:H10, O91:H21, O113:
H21, and O174:H2), possessed two toxin type 2 variants
(stx2-vhb/stx2 or stx2-vhb/stx2-vha).
The stx2d subtype was infrequently detected among isolates
included in this report (10%). Consistent with previous re-
ported findings suggesting that the Stx2d-producing strains
might be less pathogenic for humans (34, 53), the stx2d subtype
was more frequent in seropathotype D (low incidence in hu-
mans and no association with severe disease) and rare (only
one isolate) in seropathotypes A and B (associated with HUS
and outbreaks). The stx2e subtype associated with porcine
edema disease (18) was only detected on four isolates (from
seropathotypes D and E).
Interestingly, the newly identified subtype stx2-NV206 was
detected among 11% of the studied strains. All but one
stx2-NV206-positive strain carried only one stx gene. Analysis
of the distribution of stx2-NV206 indicates that the prevalence
of stx2-NV206 differed considerably among the different sero-
pathotypes. The difference in the prevalence of stx2-NV206 be-
tween seropathotypes D and E (not linked with disease) and
seropathotypes A, B, and C (linked to severe disease) was
highly significant, revealing stx2-NV206 as a significant predictor
of seropathotypes not associated with severe disease (P 
0.0001; OR  12.1 [95%CI  2.7 to 50.6]).
Phylogenetic distribution of the STEC strains. Phylogenetic
analyses revealed that the studied STEC strains segregated
mainly in phylogenetic group B1 (201 of 287 [70%]). Of the
remaining strains, 53 (19%) and 29 (10%) segregated in phy-
logenetic groups A and D, respectively. As expected from
previous studies (13, 14), phylogenetic group B2, which is pre-
dominant among extraintestinal strains, was rarely found in
STEC (two isolates).
Among the phylogenetic group B1 strains, only 15% (31 of
201 isolates) were eae positive. All of the non-O157 strains with
eae fell into this phylogenetic group. According to other studies
(13, 16, 22), the O103:H2 strains (six isolates) were classified as
STEC 2 and the strains of serotypes O26:H11, O26:NM, O111:
H2, and O111:NM (ten isolates) were classified as EHEC 2.
The 15 remaining eae-positive strains belonging to phyloge-
netic group B1 (of 12 different serotypes such as OR:H25,
O5:NM, O49:NM, O84:NM, O98:NM, and O157:H26) were
designated as EHEC-B1. Of the 170 eae-negative isolates of
phylogenetic group B1, 41 isolates of serotypes ON:H21, O91:
H21, O113:H21, and O174:H21 were classified according to
Whittam and coworkers as STEC 1. The remaining 129 isolates
lacking eae (of 57 different serotypes) were designated
STEC-B1 (major serotypes were OR:H5, OR:H8, O22:H8,
O22:H16, O46:H38, O74:H42, O91:H10, O171:H2, O172:H21,
and O174:H2).
Of the phylogenetic group D (29 isolates), 13 strains with eae
of serotypes O157:H7 and O157:NM were classified as EHEC
1. All of the 16 remaining group D strains lacked eae. These
strains of 11 different serotypes (such as O1:H18, O1:H20,
O15:H45, O23:H15, O77:H18, O105:H18, O130:H43, and
O132:H18) were designated STEC-D.
All of the 53 isolates that belonged to the phylogenetic
group A were found to lack eae. These strains, designated
STEC-A, belonged to 25 different serotypes but only 6 ac-
counted for 60% of the strains (O6:H10, O15:H16, O109:NM,
O113:H4, O136:NM, and OX178:H19).
Phylogenetic origin in relation to seropathotypes. The dif-
ferent seropathotypes were clearly distinguished by the phylo-
genetic origin of their constituting isolates (Table 3). Most of
the isolates in seropathotypes A, B, and C (associated with
human disease) belonged to a major phylogenetic group
TABLE 2. Seropathotype distribution of virulence factors and stx subtypesa
Virulence genotype Total (n  287)
No. (%) of isolates
Pa OR (95%CI)b
A (n  13) B (n  16) C (n  96) D (n  70) E (n  92)
eae 44 (15) 13 (100) 16 (100) 9 (9) 4 (6) 2 (2) 0.0001 11.6 (4.6–28.1)
astA 35 (12) 1 (8) 2 (12) 3 (3) 6 (9) 23 (25) 0.001 0.23 (0.09–0.5)
HPI 39 (13) 0 9 (56) 5 (5) 8 (12) 17 (19)
stx1 variants 136 (47) 8 (61) 13 (81) 36 (38) 25 (31) 54 (59)
Only stx1 variants 49 (17) 0 9 (56) 7 (7) 10 (14) 23 (25)
stx1 117 (41) 8 (61) 13 (81) 31 (32) 16 (23) 49 (53)
stx1c 18 (6) 0 0 3 (3) 7 (10) 8 (10) 0.01 0.24 (0.07–0.8)
stx2 variants 236 (82) 13 (100) 7 (43) 87 (90) 60 (85) 69 (76)
Only stx2 variants 151 (53) 5 (38) 3 (19) 58 (60) 48 (68) 37 (40)
stx1 variatns  stx2
variants
86 (30) 8 (61) 5 (31) 29 (30) 12 (17) 32 (35)
stx2 96 (33) 10 (77) 6 (37) 38 (39) 16 (23) 26 (28) 0.002 2.17 (1.2–3.6)
stx2-vha 58 (20) 4 (31) 1 (6) 29 (30) 16 (23) 8 (9) 0.01 2.15 (1.2–3.8)
stx2-vhb 91 (32) 0 0 54 (56) 17 (24) 20 (21) 0.0002 2.61 (1.5–4.2)
stx2-nv206 32 (11) 0 0 1 (1) 14 (20) 17 (19) 0.0001 0.03 (0.004–0.2)
stx2d 29 (10) 0 1 (6) 7 (7) 16 (23) 5 (5)
stx2e 4 (1) 0 0 0 3 (4) 1 (1)
stx2/stx2-vhb 30 (10) 0 0 19 (20) 4 (6) 7 (7)
stx2-vha/stx2-vhb 21 (7) 0 0 16 (17) 4 (6) 1 (1) 0.002 4.61 (1.6–12.9)
a P values (from chi-square test) are shown only if P was 0.01.
b Seropathotypes A, B, and C, combined (associated with disease) are compared to seropathotypes D and E, combined (not associated with disease) and taken as
the reference.
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(group D for seropathotype A and group B1 for seropatho-
types B and C). In contrast, isolates in seropathotypes D and E
(not associated with disease) appeared to be genetically more
heterogeneous. In seropathotype D, 63% of the isolates be-
longed to group B1, 28% belonged to group A, 6% belonged to
group D, and 3% belonged to group B2. Nonhuman isolates in
seropathotype E belonged either to phylogenetic group B1
(53%) or to phylogenetic group A (37%), and a small propor-
tion (10%) belonged to phylogenetic group D. Virulent clonal
groups (STEC 1, STEC 2, EHEC 1, and EHEC 2) were pre-
dominantly distributed among seropathotypes associated with
disease (A, B, and C). In contrast, “atypical” groups (e.g.,
STEC-A and STEC-D) were concentrated within seropatho-
types that are not associated with disease (D and E).
Of particular interest was the clear association observed
between phylogenetic group A and the “non virulent” sero-
pathotypes (D and E) (P  0.0001; OR  63.2 [95%CI  8.6
to 464]). In view of this association, the phylogenetic group A
status appears highly predictive of the “nonvirulent” sero-
pathotypes.
Phylogenetic distribution of VFs. To investigate the relation-
ships between genetic background and virulence genes, we
assessed the phylogenetic distribution of the VFs. The distri-
bution of VFs in the different phylogenetic and clonal groups
is shown in Table 4. Compared to phylogenetic groups D and
B1 (combined), the phylogenetic group A exhibited a signifi-
cant higher prevalence of various VFs analyzed (specifically,
astA, HPI, stx1c, and stx2-NV206). In contrast, eae, stx2, stx2-vha,
and stx2-vhb were significantly more prevalent among phyloge-
netic groups D and B1 than in phylogenetic group A.
The difference in the prevalence of eae between phyloge-
netic group D and group B1 (P  0.004) and group A (P 
0.001) was highly significant, favoring isolates in phylogenetic
group D. The difference in the prevalence of HPI and astA
genes between phylogenetic group A on the one hand and
phylogenetic groups B1 and D on the other was highly signif-
TABLE 3. Phylogenetic distribution of isolates among the different seropathotypes
Phylogenetic
group
Clonal group or
group of strains
No. (%) of isolates
A (n  13) B (n  16) C (n  96) D (n  71) E (n  92)
B1 STEC 2 0 6 (33) 0 0 0
EHEC 2 0 10 (67) 0 0 0
EHEC-B1 0 0 10 (10) 3 (4) 2 (2)
STEC 1 0 0 36 (38) 5 (7) 0
STEC-B1 0 0 46 (48) 37 (53) 47 (51)
D EHEC 1 13 (100) 0 0 0 0
STEC-D 0 0 3 (3) 4 (6) 9 (10)
A STEC-A 0 0 0 19 (28) 34 (37)
B2 B2 0 0 0 2 (3) 0
a , group of strains.
TABLE 4. Phylogenetic distribution of virulence factors and stx subtypes
Virulence genotype
No. (%) of isolates
Pa OR (95%CI)bD B1 A
Overall
(n  29)
EHEC 1
(n  13)
STEC-D
(n  16)
Overall
(n  201)
STEC 1
(n  41)
STEC-B1
(n  129)
EHEC 2, STEC 2,
EHEC-B1 (n  31)
STEC-A
(n  53)
eae 13 (42) 13 (100) 0 31 (15) 0 0 31 (100) 1 (2) 0.01 0.08 (0.01–0.59)
astA 2 (6) 1 (7) 1 (5) 12 (6) 1 (2) 8 (6) 3 (10) 21 (40) 0.01 2.64 (1.4–4.9)
HPI 1 (3) 0 1 (5) 18 (9) 1 (2) 7 (5) 10 (34) 22 (41) 0.0001 7.46 (3.6–15.3)
stx1 variants 19 (61) 8 (61) 11 (61) 93 (46) 8 (20) 64 (47) 21 (71) 23 (42)
Only stx1 variants 2 (6) 0 2 (11) 28 (14) 1 (2) 12 (9) 15 (52) 18 (34) 0.001 3.04 (1.5–5.9)
stx1 18 (58) 8 (61) 10 (56) 82 (41) 7 (17) 56 (43) 19 (61) 16 (30)
stx1c 1 (3) 0 1 (5) 7 (3) 1 (2) 6 (4) 0 7 (13) 0.01 4.08 (1.4–11.8)
stx2 variants 29 (93) 13 (100) 16 (89) 172 (85) 39 (95) 118 (87) 15 (48) 37 (70)
Only stx2 variants 12 (38) 5 (38) 7 (39) 108 (54) 33 (80) 66 (51) 9 (29) 31 (58)
stx1  stx2 variants 17 (55) 8 (61) 9 (50) 65 (32) 7 (17) 52 (38) 6 (19) 5 (9) 0.001 0.18 (0.07–044)
stx2 16 (52) 11 (85) 5 (27) 73 (36) 14 (34) 51 (37) 8 (26) 7 (13) 0.001 0.23 (0.1–0.53)
stx2-vha 4 (13) 4 (31) 0 53 (26) 16 (39) 31 (23) 6 (19) 2 (4) 0.001 0.12 (0.3–0.51)
stx2-vhb 5 (16) 0 5 (29) 83 (41) 32 (78) 49 (36) 2 (6) 5 (9) 0.001 0.16 (0.6–0.42)
stx2-nv206 0 0 0 5 (2) 0 5 (4) 0 23 (43) 0.0001 32.6 (11.6–92)
stx2d 1 (3) 0 1 (5) 24 (12) 3 (7) 15 (11) 6 (19) 4 (7)
stx2/stx2-vhb 0 0 0 29 (14) 12 (29) 17 (13) 0 1 (2)
stx2-vha/stx2-vhb 0 0 0 20 (10) 11 (27) 7 (5) 2 (6) 1 (2)
a P values (from chi-square test) are shown only if P was 0.01.
b Phylogenetic group A compared to phylogenetic groups D and B1 combined and taken as the reference.
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icant for HPI (P  0.0001) and astA (P  0.01), favoring
phylogenetic group A (STEC-A). Consistent with vertical in-
heritance of HPI within lineages, all strains belonging to sero-
types O6:H10, O26:H11, and O109:NM possessed the HPI
determinants. In contrast, and consistent with horizontal trans-
fer within lineages, the distribution pattern of astA showed
variability among strains belonging to the same serotype. The
substantial prevalence (35%) of HPI within the clonal group
EHEC 2 was due to the constant presence of HPI in strains of
serotypes O26:H11, O26:NM, O111:H2, and O111:NM.
Distribution of the stx genes was analyzed in relation to the
phylogenetic origin of the isolate (Table 4). The difference in
the prevalences of stx1 or stx2 variants between the different
phylogenetic groups was not significant. It is well documented
that isolates producing Stx1 are more rarely associated with
serious disease than isolates producing Stx2 alone. Consistent
with this finding, a substantial prevalence (34%) of strains
possessing only the stx1 variants was observed in phylogenetic
group A. Among these strains a substantial part (28%) possess
the stx1c subtype which is predominantly recovered from
healthy animals, asymptomatic infection or uncomplicated di-
arrhea in humans (53).
The distribution pattern of the different stx2 subtypes dif-
fered considerably between the phylogenetic groups. The dif-
ference in the prevalence of stx2 between phylogenetic groups
D and B1 (P 0.01) and between groups D and A (P 0.001)
was highly significant, favoring isolates in phylogenetic group
D (concentrated into the clonal group EHEC 1). The differ-
ence in the prevalence of stx2-NV206 between phylogenetic
group A and the phylogenetic groups B1 and D (combined)
was also highly significant (P  0.0001; OR  32.6 [95%CI 
11.6 to 92]), revealing a close association between stx2-nv206 and
phylogenetic group A. Indeed, among the phylogenetic group
A, the predominant stx2 genotype was the stx2-nv206 genotype,
accounting for 62% of the stx2-positive isolates.
There was a significant difference in the prevalence of
stx2-vha between phylogenetic groups B1 and A (P  0.001)
favoring isolates in phylogenetic group B1. The distribution
patterns of stx2-vha in group B1 suggest a vertical inheritance
within certain lineages (O91:H10, O91:H21, O113:H21, and
O172:H21). A similar phylogenetic distribution was observed
with stx2-vhb, with a significant difference in the prevalence of
stx2-vhb between phylogenetic group B1 and D (P  0.03; OR
 2.4 [95%CI  0.9 to 5.8]) and between groups B1 and A (P
 0.001; OR 7.3 [95%CI 2.7 to 18.4) also favoring isolates
in phylogenetic group B1. The distribution patterns of stx2-vhb
in group B1 suggest both vertical inheritance and horizontal
transfer within lineages. Consistent with horizontal transfer, a
strain-to-strain distribution of stx2-vhb was observed in sero-
types O22:H16, O91:H10, and O174:H2. In contrast and con-
sistent with vertical inheritance, stx2-vhb was detected in all
strains belonging to serotypes O91:H21, O113:H21, and O174:
H21, which are the archetypal strains of the clonal group STEC
1. The combination of stx2 and stx2-vhb was restricted to isolates
in phylogenetic group B1 (the most frequent serotypes are
O74:H42, O91:H21, and O113:H21).
When the 170 strains lacking eae in the phylogenetic group
B1 were stratified dichotomously as serotypes associated with
disease (seropathotype C [81 isolates]) versus serotypes not
associated with disease (seropathotypes D plus E [89 isolates]),
the only significant difference in the prevalence of VF between
the two groups of strains was observed with stx2-vhb. The prev-
alence of stx2-vhb within group B1 was nearly twice as high
(62% versus 32%) among isolates in the seropathotype C than
among isolates in “nonvirulent” seropathotypes (D plus E,
combined). The finding that an apparent association exists
between stx2-vhb and seropathotype C revealed stx2-vhb as a
significant predictor of the “virulent” status among group B1
isolates lacking eae (P  0.0001; OR  6.70 [95%CI  3.6 to
12.0]). When only STEC 1 strains in seropathotype C were
compared to isolates in seropathotypes D and E, stx2-vhb ap-
peared to be an even stronger predictor of “virulent” status (P
 0.0004; OR  8.2 [95%CI  3.4 to 19.4]).
DISCUSSION
To our knowledge, our study is the first to provide an over-
view of characteristics of STEC strains classified in different
seropathotypes by combining the prevalence of several known
virulence determinants and their classification into the major
phylogenetic groups of the E. coli species. Consistent with
previous studies on EPEC and STEC strains (13, 14), our
phylogenetic analysis shows that STEC strains segregate
mainly in phylogenetic group B1 and confirms the rarity of the
phylogenetic group B2. Of the remaining strains, phylogenetic
groups A and D represent, respectively, 20 and 10% of the
collection.
We provide here novel insights into the phylogenetic struc-
ture of the different seropathotypes. The presence in sero-
pathotypes that are associated with disease (A, B, and C) of
well-known virulent clonal groups (STEC 1, STEC 2, EHEC 1,
and EHEC 2) and their concomitant replacement by “atypical”
groups (e.g., STEC-A and STEC-D) in seropathotypes that are
not associated with disease (D and E) support the concept of
the seropathotype classification proposed by Karmali et al.
(22).
From the whole data analysis, we show that there is a link
between seropathotype classification, prevalence of various
VFs, and phylogeny. The astA gene which is widely distributed
among diarrheogenic E. coli strains in humans and animals
may represent an additional virulent determinant of STEC
strains (15, 38). Consistent with previous studies on human
STEC infections (45), our study confirms the presence of the
astA gene among strains carrying eae associated with HUS and
outbreaks (O26:H11, O111:H2, and O157:H7). However, the
astA gene was mostly (92%) recovered from strains lacking eae
that belonged predominantly (70%) to phylogenetic group A
(STEC-A). Of these strains, over half possessed only the stx1
variants and were distributed in seropathotypes not associated
with disease (D and E). Whether STEC-A strains harboring
only the stx1 variants and astA are true pathogens needs further
elucidation.
Consistent with previous findings involving other STEC iso-
lates (20), our data show the presence of the Yersinia HPI
among both human and animal STEC isolates and confirm the
absence of HPI from O157:H7 and O157:NM strains. In the
present study a majority (61%) of the HPI-positive strains
belong to seropathotypes that are not associated with disease
(D and E). However, HPI was detected in all members of the
clonal group EHEC 2 (O26:H11, O26:NM, O111:NM, and
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O111:H2) indicating that the HPI is a common component of
the genome of these strains and suggesting a high degree of
stability of HPI in the genome of certain lineages. To explain
the presence of HPI among STEC strains, Karch et al. (20)
formed the hypothesis that HPI in STEC is a form of fitness
island rather than a PAI. Similarly to the distribution of the
astA gene, HPI was predominantly recovered from strains lack-
ing eae distributed in seropathotypes D and E. Although the
significance of these findings remains to be established, the
present study reveals that astA and HPI were significantly
predictive, among eae-negative isolates, of the “nonvirulent”
seropathotypes.
There is considerable epidemiological evidence indicating
that STEC isolates producing Stx2 alone are more commonly
associated with serious disease than isolates producing Stx1
only or both Stx1 and Stx2 (27, 32, 41, 42). Many isolates
produce two or more Stx2 variants, but the relative contribu-
tion of each variant to the pathogenesis is not known. In the
present study, the 287 STEC isolates were subjected to stx2
subtyping. The stx2 subtype was prominent and was widely
distributed among the different seropathotypes. Consistent
with previous reports involving bovine non-O157 STEC (2, 8),
stx2-vhb was also frequently detected, and the combination stx2/
stx2-vhb was the most frequent among STEC possessing more
than one stx2 subtype. Melton-Celsa et al. (28) demonstrated
that the Stx2c variants (Stx2-vha and Stx2-vhb) are activatable by
intestinal mucus which causes a marked increase in toxicity and
may compensate for a lack of other virulence components such
as the LEE. Our data showing the confinement of stx2-vhb to
eae-negative isolates support this hypothesis. In contrast to
stx2, the prevalence of stx2-vhb differed considerably among the
different seropathotypes. Indeed, the prevalence of stx2-vhb was
twice as high among isolates associated with HUS (seropatho-
type C) than among isolates that are not associated with dis-
ease (seropathotypes D plus E), revealing stx2-vhb as a signifi-
cant predictor of “virulent” status. In addition, our
phylogenetic analysis indicates that stx2-vhb segregates mainly
within phylogenetic group B1 and is concentrated in the clonal
group STEC 1. Moreover, the distribution pattern of stx2-vhb
suggests a vertical inheritance of stx2-vhb in serotypes ON:H21,
O91:H21, O113:H21, and O174:H21, which are the best known
serotypes of the clonal group STEC 1. These findings indicate
that stx2-vhb is a common component of the genome of certain
lineages in STEC 1 and suggest an important role of the stx2-vhb
subtype in the pathogenesis of these lineages. Consistent with
this hypothesis, a major role of the Stx2-activatable variants
(Stx2-vha and Stx2-vhb) was recently demonstrated in the patho-
genesis of the eae-negative strain B2F1 (O91:H21) in neonatal
pigs (11). In that study, while the absence of intimin and
plasmid-associated virulence determinants had little impact on
the pathogenesis of STEC disease during infection, an appar-
ent association between the severity of lesions in pigs and the
production of the Stx2-activatable toxin was observed.
Our results demonstrate a close association between
stx2-NV206 and STEC-A and reveals stx2-NV206 as a strong pre-
dictor of the “nonvirulent” seropathotypes E and D. Consid-
ering the high cytotoxic activity of the Stx2-NV206 variant ob-
served in vitro toward Vero cells (2), the substantial prevalence
(42%) of stx2-NV206 in STEC-A was unexpected. The observed
link between stx2-NV206 and STEC-A may result either from the
preferential association of a given phage with a particular ge-
netic background or from a coevolution of the bacteria and
phage chromosomes (47). Although the role of stx2-NV206 in
pathogenesis of STEC disease remains to be established, the
strong association observed between stx2-NV206 and STEC-A
supports the concept that arrival, retention, and/or expression
of virulence factors require a particular genetic background
(14).
One limitation of the present study results from the collec-
tion, which included multiple representatives of certain geno-
types from different sources. This has resulted, for example, in
a disproportionate representation of certain clones that inflate
the apparent prevalence of VFs associated with these clones
(for example, O113:H4, O113:H21, and O174:H2). As sug-
gested by Johnson et al. (16), to protect against this bias, we
used a more-stringent-than-usual criterion for statistical signif-
icance (P  0.01).
One of the major findings of the present study is the dem-
onstration of a striking phylogenetic distribution of various
VFs. Specifically, when group A was compared to other phy-
logenetic groups combined, significant differences in preva-
lence favoring group A were seen for stx1c, stx2-NV206, astA, and
HPI. Taken together with the observation that STEC-A com-
prises exclusively strains from seropathotypes that are not as-
sociated with disease, their “atypical” virulence pattern sug-
gests that STEC-A isolates comprise a distinct category of
STEC strains. The ability to identify STEC-A isolates is of
clinical and epidemiological significance because these isolates
are not commonly associated with human disease. Because of
the geographically circumscribed study population, further ep-
idemiological investigations on other STEC populations are
needed to generalize these results.
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